Wiesbaden, Germany

Klaus Schneider

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Merck Patent Gmbh, Pfizer Corporation. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Klaus Schneider. Retrieved from https://idiyas.com/inventor/klaus-schneider-xct2ahf6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Klaus Schneider: Innovator in Diagnostic Antibodies

Introduction

Klaus Schneider is a notable inventor based in Wiesbaden, Germany. He has made significant contributions to the field of diagnostics, particularly in the development of antibodies that target specific proteins in human tissues. His work has implications for patient stratification and personalized medicine.

Latest Patents

Klaus Schneider holds a patent for a "Diagnostic anti-PD-L1 antibody and use thereof." This invention provides an antibody or antigen-binding fragment that binds to an epitope within human PD-L1 with high specificity and reproducibility. The inventive antibody can be utilized in assessing PD-L1 expression in tissue samples, aiding in the stratification of patients. Additionally, the patent outlines methods for producing this innovative antibody.

Career Highlights

Throughout his career, Klaus Schneider has worked with prominent companies in the pharmaceutical industry, including Merck Patent GmbH and Pfizer Corporation. His experience in these organizations has allowed him to contribute to significant advancements in medical diagnostics.

Collaborations

Klaus Schneider has collaborated with esteemed colleagues, including Claudia Wilm and Heike Dahmen. Their combined expertise has furthered the development of innovative solutions in the field of diagnostics.

Conclusion

Klaus Schneider's contributions to the field of diagnostic antibodies exemplify the impact of innovation in medicine. His work continues to influence patient care and treatment strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…